Learn more

NANJING MATERNITY & CHILD HEALTH HOSPITAL

Overview
  • Total Patents
    61
  • GoodIP Patent Rank
    23,990
  • Filing trend
    ⇧ 550.0%
About

NANJING MATERNITY & CHILD HEALTH HOSPITAL has a total of 61 patent applications. It increased the IP activity by 550.0%. Its first patent ever was published in 2016. It filed its patents most often in China. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are TOKYO METROPOLITAN INST MEDICAL SCIENCE, BOSTON MEDICAL CT CORP and ZOLLO MASSIMO.

Patent filings in countries

World map showing NANJING MATERNITY & CHILD HEALTH HOSPITALs patent filings in countries
# Country Total Patents
#1 China 61

Patent filings per year

Chart showing NANJING MATERNITY & CHILD HEALTH HOSPITALs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Ji Chenbo 16
#2 Cui Xianwei 11
#3 Guo Xirong 9
#4 Shen Rong 8
#5 Xu Zhengfeng 8
#6 Zhao Chun 8
#7 Jia Xuemei 6
#8 Zhang Junqiang 6
#9 Hu Ping 6
#10 Zeng Xin 6

Latest patents

Publication Filing date Title
CN112226439A Pathogenic mutation of hereditary gametogenesis disorder and detection reagent thereof
CN111848740A Vaginal secretion derived polypeptide and application thereof in inhibiting candida albicans infection
CN111863255A High-risk pregnant and lying-in woman risk assessment early warning system and method thereof
CN111679073A Application of KLK13 in preparation of cervical adenocarcinoma diagnosis detection kit
CN111650381A Application of protein marker or combination thereof in preparation of acute mastitis diagnosis kit
CN111808189A Preparation method of polyclonal antibody of specific recognition protein PABPN1L
CN111035484A Artificial breast
CN111001079A Mammary duct positioning device
CN111004818A LGI1 gene mutation and application thereof in preparation of temporal lobe epilepsy co-morbid depression animal model
CN110938113A Application of immunoregulation peptide in preparing immunopotentiation medicine
CN111855625A CA125 detection kit based on Cu-MOF and application thereof
CN111617249A Application of hsa _ circ _0007444 in preparation of medicine for treating ovarian cancer
CN110882009A Intelligent visual cervical mucus sampling device and cervical detection screening method
CN110684827A Cervical cancer staging method and detection kit based on cervical exfoliated cell gene detection
CN111620939A Polypeptide ZYX for treating or assisting in treating ovarian cancer36-58
CN111617248A Application of RFPL1S-201 in preparing medicine for inhibiting ovarian cancer proliferation, invasion and/or metastasis
CN110592004A Method for inducing human iPSCs or ESCs to differentiate into brown adipocytes
CN110628712A Preparation method and application of therapeutic interstage mesenchymal stem cells based on induced pluripotent stem cells
CN110456036A Application of the metabolic markers in the kit for preparing Diagnosis of Congenital Heart Disease
CN112048017A In-vitro maturation culture method for oocyte